"His resignation was considered and accepted by the board of directors in its meeting today. N Govindarajan will be relieved from the services of the company effective from the close of business on December 31, 2021," Aurobindo Pharma said in a regulatory filing.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Yl6iSZ
via IFTTT
0 comments:
Post a Comment